跳转至内容
Merck
CN

B0375

Sigma-Aldrich

巴比妥

别名:

5,5-二乙基-2,4,6(1H,3H,5H)-嘧啶三酮, 5,5-二乙基巴比妥酸, 佛罗拿, 巴比通

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C8H12N2O3
化学文摘社编号:
57-44-3
分子量:
184.19
Beilstein:
163999
EC 号:
200-331-2
MDL编号:
MFCD00036212
UNSPSC代码:
51361926
PubChem化学物质编号:
24891513
NACRES:
NA.21

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

表单

powder

质量水平

200

药品控制

USDEA Schedule IV; Home Office Schedule 3; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

forensics and toxicology
pharmaceutical (small molecule)
veterinary

SMILES字符串

CCC1(CC)C(=O)NC(=O)NC1=O

InChI

1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)

InChI key

FTOAOBMCPZCFFF-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

<ul>
<li><strong>一些嘧啶、嘌呤、氨基酸和混合配体复合物的合成与表征： </strong> 本研究探讨了巴比妥在各种配体复合物合成中的应用，重点介绍了其在生命科学试剂和医药中间体开发中的应用。这可以为使用巴比妥作为关键中间体的制药研发策略提供参考（Masoud et al., 2008）。</li>
</ul>

生化/生理作用

镇静剂/催眠药

象形图

Exclamation mark
GHS07

警示用语：

Warning

危险声明

H302

预防措施声明

P301 + P312 + P330

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

监管及禁止进口产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000434895
0000434897
0000434895
0000434897
0000416223

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Marlies Oostendorp et al.
Transfusion, 55(6 Pt 2), 1555-1562 (2015-05-20)
Monoclonal antibodies (MoAbs) are increasingly integrated in the standard of care. The notion that therapeutic MoAbs can interfere with clinical laboratory tests is an emerging concern that requires immediate recognition and the development of appropriate solutions. Here, we describe that
J M Bossert et al.
Behavioural pharmacology, 14(7), 517-523 (2003-10-15)
We have shown previously that 15 mg/kg pentobarbital induces a conditioned place preference (CPP), but it is unsuitable for intracranial administration. Since the long-acting barbiturate, sodium barbital, is soluble at a neutral pH, we tested whether it would induce a
Meiling Wang et al.
Journal of chromatography. A, 1217(17), 2821-2831 (2010-03-17)
This work describes a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for multiplex screening, ultratrace quantification and reliable confirmation of barbital series residues in animal-derived food matrices. The method is developed based on a distinct dependency of the electrospray ionization (ESI)
Mamdouh S Masoud et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 69(1), 230-238 (2007-05-25)
Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes of barbital, thiouracil, adenine, amino acids (methionine, lysine and alanine) and some mixed ligands were prepared and characterized by elemental analyses, IR, electronic spectra, magnetic susceptibility and ESR spectra. Coordination of
Haixiang Zhao et al.
Analytica chimica acta, 586(1-2), 399-406 (2007-03-28)
A new method was developed for the rapid screening and confirmation analysis of barbital, amobarbital and phenobarbital residues in pork by gas chromatography-tandem mass spectrometry (GC/MS/MS) with ion trap MSD. The residual barbiturates in pork were extracted by ultrasonic extraction
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持